| Literature DB >> 36079356 |
Adrianna Sławińska1, Malgorzata Tyszka-Czochara2, Paweł Serda3, Marcin Oszajca3, Małgorzata Ruggiero-Mikołajczyk1, Katarzyna Pamin1, Bogna D Napruszewska1, Ewelina Prochownik2, Wiesław Łasocha1,3.
Abstract
Two organic-inorganic hybrids based on sodium peroxidomolybdates(VI) and 3,5-dicarboxylic pyridine acid (Na-35dcpa) or N-oxide isonicotinic acid (Na-isoO) have been synthesized and characterized. All compounds contain inorganic parts: a pentagonal bipyramid with molybdenum center, and an organic part containing 3,5-dicarboxylic pyridine acid or N-oxide isonicotinic acid moieties. The type of organic part used in the synthesis influences the crystal structure of obtained compounds. This aspect can be interesting for crystal engineering. Crystal structures were determined using powder X-ray diffraction or single crystal diffraction for compounds Na-35dcpa and Na-isoO, respectively. Elemental analysis was used to check the purity of the obtained compounds, while X-ray Powder Diffraction (XRPD) vs. temp. was applied to verify their stability. Moreover, all the compounds were examined by Infrared (IR) spectroscopy. Their catalytic activity was tested in the Baeyer-Villiger (BV) oxidation of cyclohexanone to ε-caprolactone in the oxygen-aldehyde system. The highest catalytic activity in the BV oxidation was observed for Na-35dcpa. The compounds were also tested for biological activity on human normal cells (fibroblasts) and colon cancer cell lines (HT-29, LoVo, SW 620, HCT 116). All compounds were cytotoxic against tumor cells with metastatic characteristics, which makes them interesting and promising candidates for further investigations of specific anticancer mechanisms.Entities:
Keywords: Baeyer–Villiger oxidation; X-ray powder data; catalysis; crystal structure analysis; cytotoxicity; peroxidomolybdates; thermal decomposition
Year: 2022 PMID: 36079356 PMCID: PMC9457328 DOI: 10.3390/ma15175976
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.748
Summary of crystal data of the investigated compounds.
| Compound Code, | Na-35dcpa, | Na-isoO, |
|---|---|---|
| Chemical formula | C7 H10 Mo N Na O13 | C6 H8 Mo N Na O10 |
| Chemical formula, structural | Na[MoO(O2)2C5H3NO(COO) (COOH)]·3H2O | Na[MoO(O2)2C6H4NO (COO)]·2H2O |
| MW (g/mol) | 435.09 | 373.06 |
| 293 | −173 | |
| Wavelength λ [Å] | CuKα: 1.54187 | CuKα: 1.54184 |
| Crystal system, SG | triclinic, P-1 | monoclinic, P2(1)/c |
| Cell parameters: | ||
| 12.2307 (7) | 11.6753 (2) | |
| 12.2653 (7) | 13.4514 (3) | |
| 8.9485 (6) | 7.2919 (2) | |
| 97.167 (4) | 90.0 | |
| 101.840 (3) | 93.602 (2) | |
| 87.893 (5) | 90.0 | |
| V(Å3) | 1303.48 (14) | 1142.92 (4) |
| Z, calculated density (g/cm3) | 4, 2.21 | 4, 2.156 |
| Absorption coefficient (mm−1) | 9.079 | 10.323 |
| F(000) | 740 | 728 |
| Theta range [°] | 5.007–79.992 | 3.793–80.579 |
| Limiting indices | −10≤h≤9; −10≤k≤10; 0≤l≤7 | −14≤h≤14; −17≤k≤16; −8≤l≤9 |
| completeness to theta | 100% (powder sample) | 80.579, 98.2% |
| Absorption correction | Capillary, calc. for cylindrical sample | Multi-scan |
| refinement method | Rietveld | F2 (Fsqd) |
| Data/restraints/parame-ters | 5712/83/86 | 2462/0/176 |
| goodness of fit (on F2 in s.c.) | 4.45 | 1.113 |
| Final R indices | Rp = 0.0434, Rwp = 0.0632 | R1 = 0.0575, wR2 = 0.1306 |
| R indices (all data) | RF = 0.0644 | R1 = 0.0526, wR2 = 0.1281 |
| Largest difference peak and hole (eA−3) | 0.57, −0.47 | 0.775, −1.479 |
| CCDC | 2170626 | 2171243 |
Figure 1One of two centrosymmetric dimers in the asymmetric unit of Na-35dcpa (a); packing diagram of Na-35dcpa along the a-axis (b), along the b-axis (c), along the c-axis (d).
Figure 2The asymmetric unit of Na-isoO (a); packing diagram of Na-isoO along the a-axis (b), along the b-axis (c), along the c-axis (d).
IR spectra vibrations and band assignments connected with oxodiperoxido- molybdate [3,9,10,11,12,31,43,44,45,46]. Vs—very strong, s—strong, m—medium, w—weak.
| Compound | ν (Mo=O) | νsym (O-O) | νasym (Mo-(O)2) | νsym (Mo-(O)2) | (N-Oxide) Vibrations |
|---|---|---|---|---|---|
|
| 956 vs, 969 s | 861 vs | 580 s | 523 m | 493 w, 797 w |
|
| 953 s | 867 vs, 586 vs | 582 s | 544 m | 814 w |
Figure 3IR spectra of the compounds Na-35dcpa and Na-isoO. All range (400–4000 L/cm) wavenumber is presented in Figure S2.
Figure 4XRPD vs. temperature: thermal decomposition studies of the compound Na-35dcpa (see text for description). The estimated from Scherrer equation size of crystallites (initial phase 25 °C) was about ~75 nm (see Table S2 for details).
Figure 5XRPD vs. temperature: thermal decomposition studies of the compound Na-isoO (see text for description). The estimated from Scherrer equation size of crystallites (at 25 °C) was about ~65 nm (see Table S3 for details).
N2 physisorption-derived parameters characterizing the obtained samples (SSA—specific surface area).
| Compound | SSA (m2/g) | Pore Size | Pore Volume |
|---|---|---|---|
|
| ≤1 | 33, 62, 260 | 0.026 |
|
| ≤1 | 53, 157 | 0.068 |
| Na-nicO | 2.48 | 33, 62, 115 | 0.028 |
Cytotoxic effects (IC50, μM/L) as mean values with estimated SD of Na-isoO, Na-35dcpa, Na-nicO against normal human fibroblasts (BJ) and human tumor cells (HT-29, LoVo, SW 620, HCT 116). Experiments were repeated three times with similar results.
| Compound | Normal Cells | Human Colon Tumor Cells | |||
|---|---|---|---|---|---|
|
|
| ||||
| Fibroblasts | HT-29 | LoVo | SW 620 | HCT 116 | |
|
| 40 ± 4.9 | 105 ± 9.1 | 21.1 ± 4.3 | 28.2 ± 1.0 | 38.1 ± 9.6 |
|
| 87.9 ± 0 | 131.2 ± 6.9 | 30.6 ± 0.8 | 76.7 ± 1.7 | 51.3 ± 8.7 |
|
| 28.5 ± 0.4 | 82.9 ± 11.8 | 14.6 ± 2.0 | 26.9 ± 3.7 | 24.1 ± 2.7 |
Figure 6Comparative plot of IC50 values [μM] of Na-isoO, Na-35dcpa and Na-nicO against normal human fibroblasts (BJ) and human tumor cell lines (HT-29, LoVo, SW 620, HCT 116). Arrow up means higher value than presents on graph – see details on Table 4.
The BV oxidation of cyclohexanone using molybdenum complexes.
| Catalyst Number and Code | Conversion [%] | Yield [%] | Selectivity [%] | TON |
|---|---|---|---|---|
|
| 45.4 | 41.5 | 91.4 | 190.9 |
|
| 50.0 | 48.8 | 97.6 | 224.5 |
| Na-nicO | 49.1 | 32.3 | 65.8 | 148.58 |
| Selected examples from previous studies [ | ||||
| K-35dcpa | 90.9 | 89.7 | 98.7 | 412.62 |
| K-isoO | 37.6 | 6.8 | 18.1 | 31.28 |
| K-nicO | 44.7 | 35.6 | 79.6 | 163.76 |
Figure 7Scheme of the catalytics of the BV cyclohexanone oxidation with molecular oxygen and peroxidomolybdates as catalysts [31].